Cancer Research TCM Europe  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dias, C. S.
Right arrow Articles by Evans, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dias, C. S.
Right arrow Articles by Evans, S. C.
[Cancer Research 66, 9467-9473, October 1, 2006]
© 2006 American Association for Cancer Research


Cell, Tumor, and Stem Cell Biology

Regulation of hdm2 by Stress-Induced hdm2alt1 in Tumor and Nontumorigenic Cell Lines Correlating with p53 Stability

Chrisanne S. Dias, Yan Liu, Amy Yau, Lindsay Westrick and Susan C. Evans

Department of Chemistry and Biochemistry, Edison Biotechnology Institute, Ohio University, Athens, Ohio

Requests for reprints: Susan C. Evans, Department of Chemistry and Biochemistry, Konneker Research Laboratories, Ohio University, Building 25, The Ridges-Ohio University, Athens, OH 45701. Phone: 740-597-1319; Fax: 740-593-4795; E-mail: evanss1{at}ohio.edu.

Alternative and aberrant splicing of hdm2 occurs in tumor and normal tissues. However, the factors that induce these splice variants and whether they are translated to protein products in vivo is unknown, making it difficult to decipher which of these hdm2 transcripts have a normal physiologic function or contribute to carcinogenesis. We investigated the conditions that induce this post-transcriptional modification of hdm2 in tumor and nontumorigenic cell lines. We showed that UV and {gamma} radiation as well as cisplatin treatment induced alternative splicing of hdm2, which resulted in a single splice variant, hdm2alt1, irrespective of the cell type. Interestingly, the mechanism of UV-induced splicing is independent of p53 status. Immunoanalysis revealed that, after UV radiation, HDM2ALT1 protein was expressed and interacted with HDM2 that correlated to increased p53 protein levels and its accumulation in the nucleus, whereas HDM2 localized more to the cytoplasm with a decrease in its RNA and protein level. We propose that stress-induced HDM2ALT1 regulates HDM2 at two levels, RNA and protein, further modulating the p53-HDM2 interaction or interactions of HDM2 with other cell cycle regulatory proteins. This kind of regulation may possibly restrict oncogenic functions of HDM2 and contribute to the many protective responses triggered by certain stress signals. Our data imply that HDM2ALT1 possesses a normal physiologic function in damaged cells, perhaps facilitating cellular defense. (Cancer Res 2006; 66(19): 9467-73)




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
E. L. Volk, L. Fan, K. Schuster, J. E. Rehg, and L. C. Harris
The MDM2-A Splice Variant of MDM2 Alters Transformation In vitro and the Tumor Spectrum in Both Arf- and p53-Null Models of Tumorigenesis
Mol. Cancer Res., June 1, 2009; 7(6): 863 - 869.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. He, Z. Zuo, H. Chen, L. Zhang, F. Zhou, H. Cheng, and R. Zhou
Genome-wide detection of testis- and testicular cancer-specific alternative splicing
Carcinogenesis, December 1, 2007; 28(12): 2484 - 2490.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.